For research use only. Not for therapeutic Use.
Farletuzumab-MMAE is an antibody-drug conjugate (ADC) composed of humanized anti-human folate receptor-alpha (FRα) and the cytotoxic agent monomethyl auristatin (MMAE) via a MC-Vc linker. It has a potent antitumor activity.
| Catalog Number | I047275 |
| Purity | ≥95% |
| Reference | [1] Cheng X, et al. Mol Cancer Ther (2018) 17 (12): 2665–2675. |
